Trials / Completed
CompletedNCT06444386
ECGi of SyncAV With MultiPoint Pacing
Electrocardiographic Imaging of MultiPoint Pacing and SyncAV: Understanding Optimized Programming for Cardiac Resynchronization Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this clinical study was to evaluate the impact of Multipoint Pacing (MPP) and SyncAV programming on ventricular electrical activation time and activation sequence using noninvasive electrocardiographic imaging (ECGi) in patients receiving cardiac resynchronization therapy (CRT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MPP + SyncAV | Cardiac resynchronization therapy (CRT) features of MultiPoint Pacing (MPP) and SyncAV (dynamic atrioventricular delay programming) enabled. |
Timeline
- Start date
- 2021-09-29
- Primary completion
- 2023-07-12
- Completion
- 2024-04-01
- First posted
- 2024-06-05
- Last updated
- 2024-06-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06444386. Inclusion in this directory is not an endorsement.